THAR — Tharimmune Balance Sheet
0.000.00%
- $4.95m
- $4.14m
Annual balance sheet for Tharimmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.192 | 0.004 | 6.51 | 10.9 | 3.56 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
Total Assets | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.73 | 4.53 | 1.14 | 1.82 | 2.41 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 4.01 | 5.31 | 1.14 | 1.82 | 2.41 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | -3.72 | -4.68 | 5.54 | 9.13 | 1.31 |
Total Liabilities & Shareholders' Equity | 0.295 | 0.622 | 6.69 | 10.9 | 3.72 |
Total Common Shares Outstanding |